Stock Market News1 week Pfizer Meets Goal in Non-Muscle Invasive Bladder Cancer Study Zacks
Data from a late-stage study shows that treatment with PFE’s PD-1 inhibitor when added to BCG improves outcomes in certain bladder cancer patients.
XData from a late-stage study shows that treatment with PFE’s PD-1 inhibitor when added to BCG improves outcomes in certain bladder cancer patients.
X